Selecta Biosciences has raised $151M in total funding. Latest round: Series E. Backed by OrbiMed, 5AM Ventures, Advent Life Sciences.
Selecta Biosciences has raised $151M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in September 2015. The round record for Selecta Biosciences runs through 2015; nothing later has been disclosed. Investors on record include OrbiMed, 5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures and 10 others. 16 distinct backers are named across the disclosed rounds.
Totals shown for Selecta Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026